ArticleJournal of managed care & specialty pharmacy2021

Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis.

Joshua Mooney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.